Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
Titel:
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
Auteur:
Pignata, Sandro Scambia, Giovanni Katsaros, Dionyssios Gallo, Ciro Pujade-Lauraine, Eric De Placido, Sabino Bologna, Alessandra Weber, Beatrice Raspagliesi, Francesco Panici, Pierluigi Benedetti Cormio, Gennaro Sorio, Roberto Cavazzini, Maria Giovanna Ferrandina, Gabriella Breda, Enrico Murgia, Viviana Sacco, Cosimo Cinieri, Saverio Salutari, Vanda Ricci, Caterina Pisano, Carmela Greggi, Stefano Lauria, Rossella Lorusso, Domenica Marchetti, Claudia Selvaggi, Luigi Signoriello, Simona Piccirillo, Maria Carmela Di Maio, Massimo Perrone, Francesco